Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy

• Main Authors: Christian K. Hirt (Author), Tijmen H. Booij (Author), Linda Grob (Author), Patrik Simmler (Author), Nora C. Toussaint (Author), David Keller (Author), Doreen Taube (Author), Vanessa Ludwig (Author), Alexander Goryachkin (Author), Chantal Pauli (Author), Daniela Lenggenhager (Author), Daniel J. Stekhoven (Author), Christian U. Stirnimann (Author), Katharina Endhardt (Author), Femke Ringnalda (Author), Lukas Villiger (Author), Alexander Siebenhüner (Author), Sofia Karkampouna (Author), Marta De Menna (Author), Janette Beshay (Author), Hagen Klett (Author), Marianna Kruithof-de Julio (Author), Julia Schüler (Author), Gerald Schwank (Author)
• Format: Book
• Published: Elsevier, 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Pancreatic cancer (PDAC) is a highly aggressive malignancy for which the identification of novel therapies is urgently needed. Here, we establish a human PDAC organoid biobank from 31 genetically distinct lines, covering a representative range of tumor subtypes, and demonstrate that these r...